Access to Scalp Cooling Therapy Act of 2024
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Access to Scalp Cooling Therapy Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing access to scalp cooling therapy, a treatment used to reduce hair loss during chemotherapy. The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions.
This bill sought to improve access to scalp cooling therapy for patients undergoing chemotherapy but did not progress beyond early committee referral and expired without enactment.
- The bill focuses on scalp cooling therapy, a medical intervention to mitigate chemotherapy-induced hair loss.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on December 17, 2024.
- The bill failed to advance and expired without becoming law, and no full text or official summary is publicly available.
['Cancer patients undergoing chemotherapy who may seek scalp cooling therapy to reduce hair loss', 'Healthcare providers offering scalp cooling treatments', 'Medical device manufacturers and suppliers of scalp cooling technology']
['Lack of publicly available full bill text and official summary limits understanding of specific provisions and implementation requirements', 'Unclear funding mechanisms or authority to enforce access to scalp cooling therapy', 'Potential challenges in oversight and ensuring equitable access if the bill had passed']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance further and expired, indicating limited legislative momentum or prioritization. The policy area is health, specifically related to supportive cancer care treatments.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have increased demand for scalp cooling devices and related healthcare services.', 'Potentially improved quality of life for chemotherapy patients by reducing hair loss side effects.', 'Possible increased healthcare costs or insurance coverage considerations related to scalp cooling therapy.']
The absence of full text and an official summary restricts transparency and public understanding of the bill's specific provisions and potential impacts. The bill's failure to progress beyond subcommittee referral suggests limited legislative support or prioritization. Oversight mechanisms and funding details remain unclear due to missing documentation.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.